We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Domain Therapeutics, Universite de Montreal, IRICoR and McGill University Sign Agreement

News   Dec 26, 2013

 
Domain Therapeutics, Universite de Montreal, IRICoR and McGill University Sign Agreement
 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

Cancer Drug & Antidepressants Provide Clues for Treating Fatal Brain-Eating Disease

News

Researchers have now identified three new molecular drug targets in N. fowleri, an amoeba that can infect a healthy person and cause severe primary amebic meningoencephalitis, a "brain-eating" disease The team have also identified a number of drugs that are able to inhibit the amoeba's growth in a laboratory dish.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE